Quizartinib is a kinase inhibitor approved by the FDA for the treatment of newly diagnosed acute myeloid leukemia that meets certain requirements. The brand name of Quizartinib is Vanflyta. Daiichi Sankyo Company received the approval for Vanflyta on July 20, 2023. Acute Myeloid Leukemia (AML) is a type of cancer that causes uncontrolled growth and […]
Quizartinib Mechanism of Action for Acute Myeloid Leukemia Read More »
Lotilaner is a GABA-gated chloride channel inhibitor approved by the FDA for the treatment of Demodex Blepharitis. The brand name of Lotilaner is Xdemvy. Tarsus Pharmaceuticals received the approval for Xdemvy on July 25, 2023. Demodex Blepharitis is an inflammation of the eyelids caused by the overpopulation of Demodex mites. Lotilaner causes paralysis in the Blepharitis
Lotilaner Mechanism of Action for Demodex Blepharitis Read More »
Zuranolone is a neuroactive steroid approved by the FDA for the treatment of postpartum depression. The brand name of Zuranolone is Zurzuvae. Biogen and SAGE Therapeutics received the approval for Zurzuvae on August 4, 2023. Postpartum depression (PPD) is a mood disorder that affects some individuals after childbirth. Zuranolone is a gamma-aminobutyric acid (GABA)-A receptor positive
Zuranolone Mechanism of Action for Postpartum Depression Read More »
Avacincaptad pegol is an RNA aptamer approved by the FDA for the treatment of Geographic Atrophy secondary to age-related macular degeneration. The brand name of Avacincaptad pegol is Izervay. Iveric Bio received the approval for Avacincaptad pegol on August 4, 2023. Geographic Atrophy (GA), secondary to age-related macular degeneration (AMD), involves complex changes in the cellular and molecular components of
Talquetamab is a bispecific monoclonal antibody approved by the FDA for the treatment of relapsed or refractory multiple myeloma. The brand name of Talquetamab is TALVEY. Janssen Pharmaceutical Inc. received the approval for TALVEY on August 09, 2023. Multiple Myeloma is a type of cancer that affects plasma cells causing them to overpopulate and subsequently produce the same
Talquetamab Mechanism of Action for Multiple Myeloma Read More »
Loading Comments...